nodes	percent_of_prediction	percent_of_DWPC	metapath
Lornoxicam—PTGS2—Lenalidomide—hematologic cancer	0.137	0.152	CbGbCtD
Lornoxicam—PTGS2—Thalidomide—hematologic cancer	0.0734	0.0813	CbGbCtD
Lornoxicam—PTGS1—Bortezomib—hematologic cancer	0.0711	0.0788	CbGbCtD
Lornoxicam—PTGS1—Thalidomide—hematologic cancer	0.0619	0.0686	CbGbCtD
Lornoxicam—PTGS1—Ifosfamide—hematologic cancer	0.0545	0.0604	CbGbCtD
Lornoxicam—PTGS1—Imatinib—hematologic cancer	0.0521	0.0577	CbGbCtD
Lornoxicam—PTGS2—Triamcinolone—hematologic cancer	0.0508	0.0563	CbGbCtD
Lornoxicam—CYP2C9—Bexarotene—hematologic cancer	0.0467	0.0517	CbGbCtD
Lornoxicam—PTGS2—Betamethasone—hematologic cancer	0.0436	0.0483	CbGbCtD
Lornoxicam—CYP2C9—Idarubicin—hematologic cancer	0.0387	0.0429	CbGbCtD
Lornoxicam—PTGS2—Cisplatin—hematologic cancer	0.0314	0.0348	CbGbCtD
Lornoxicam—PTGS2—Etoposide—hematologic cancer	0.0309	0.0342	CbGbCtD
Lornoxicam—CYP2C9—Bortezomib—hematologic cancer	0.0286	0.0317	CbGbCtD
Lornoxicam—PTGS1—Etoposide—hematologic cancer	0.0261	0.0289	CbGbCtD
Lornoxicam—PTGS2—Dexamethasone—hematologic cancer	0.0254	0.0281	CbGbCtD
Lornoxicam—CYP2C9—Thalidomide—hematologic cancer	0.0249	0.0276	CbGbCtD
Lornoxicam—CYP2C9—Teniposide—hematologic cancer	0.0238	0.0264	CbGbCtD
Lornoxicam—CYP2C9—Ifosfamide—hematologic cancer	0.022	0.0243	CbGbCtD
Lornoxicam—CYP2C9—Imatinib—hematologic cancer	0.021	0.0232	CbGbCtD
Lornoxicam—CYP2C9—Nilotinib—hematologic cancer	0.0191	0.0211	CbGbCtD
Lornoxicam—CYP2C9—Cisplatin—hematologic cancer	0.0107	0.0118	CbGbCtD
Lornoxicam—CYP2C9—Dexamethasone—hematologic cancer	0.00863	0.00956	CbGbCtD
Lornoxicam—PTGS2—ovarian follicle—hematologic cancer	0.00691	0.493	CbGeAlD
Lornoxicam—CYP2C9—hematopoietic system—hematologic cancer	0.000956	0.0682	CbGeAlD
Lornoxicam—PTGS1—hematopoietic system—hematologic cancer	0.000872	0.0622	CbGeAlD
Lornoxicam—PTGS2—Fluocinonide—Betamethasone—hematologic cancer	0.000838	0.209	CbGdCrCtD
Lornoxicam—PTGS2—Fluocinonide—Dexamethasone—hematologic cancer	0.000838	0.209	CbGdCrCtD
Lornoxicam—PTGS2—hematopoietic system—hematologic cancer	0.000834	0.0595	CbGeAlD
Lornoxicam—PTGS2—Fluocinonide—Triamcinolone—hematologic cancer	0.000819	0.205	CbGdCrCtD
Lornoxicam—CYP2C9—blood—hematologic cancer	0.000633	0.0452	CbGeAlD
Lornoxicam—PTGS1—blood—hematologic cancer	0.000578	0.0412	CbGeAlD
Lornoxicam—PTGS2—blood—hematologic cancer	0.000552	0.0394	CbGeAlD
Lornoxicam—PTGS2—bone marrow—hematologic cancer	0.000535	0.0381	CbGeAlD
Lornoxicam—PTGS1—lung—hematologic cancer	0.000507	0.0362	CbGeAlD
Lornoxicam—PTGS2—Fluticasone Propionate—Betamethasone—hematologic cancer	0.000506	0.126	CbGdCrCtD
Lornoxicam—PTGS2—Fluticasone Propionate—Dexamethasone—hematologic cancer	0.000506	0.126	CbGdCrCtD
Lornoxicam—PTGS2—Fluticasone Propionate—Triamcinolone—hematologic cancer	0.000494	0.124	CbGdCrCtD
Lornoxicam—PTGS2—lung—hematologic cancer	0.000484	0.0346	CbGeAlD
Lornoxicam—PTGS1—testis—hematologic cancer	0.000478	0.0341	CbGeAlD
Lornoxicam—PTGS1—lymph node—hematologic cancer	0.000347	0.0247	CbGeAlD
Lornoxicam—PTGS2—lymph node—hematologic cancer	0.000331	0.0236	CbGeAlD
Lornoxicam—CYP2C9—Metabolism—HDC—hematologic cancer	3.1e-05	0.000391	CbGpPWpGaD
Lornoxicam—PTGS2—Disease—IDH1—hematologic cancer	3.1e-05	0.00039	CbGpPWpGaD
Lornoxicam—PTGS2—Spinal Cord Injury—IL6—hematologic cancer	3.08e-05	0.000388	CbGpPWpGaD
Lornoxicam—PTGS2—Disease—GSTO1—hematologic cancer	3.06e-05	0.000386	CbGpPWpGaD
Lornoxicam—PTGS1—Metabolism—UGT1A1—hematologic cancer	3.04e-05	0.000383	CbGpPWpGaD
Lornoxicam—PTGS2—Integrated Pancreatic Cancer Pathway—VEGFA—hematologic cancer	3.02e-05	0.000381	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism—IDH2—hematologic cancer	3.02e-05	0.00038	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism—HMMR—hematologic cancer	3.02e-05	0.00038	CbGpPWpGaD
Lornoxicam—PTGS2—Disease—AGO2—hematologic cancer	3e-05	0.000378	CbGpPWpGaD
Lornoxicam—PTGS2—Disease—HDAC9—hematologic cancer	2.97e-05	0.000374	CbGpPWpGaD
Lornoxicam—PTGS1—Metabolism—SLC22A1—hematologic cancer	2.96e-05	0.000373	CbGpPWpGaD
Lornoxicam—PTGS1—Metabolism—CRABP1—hematologic cancer	2.96e-05	0.000373	CbGpPWpGaD
Lornoxicam—PTGS2—Disease—H3F3B—hematologic cancer	2.94e-05	0.00037	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism of lipids and lipoproteins—SDC1—hematologic cancer	2.89e-05	0.000364	CbGpPWpGaD
Lornoxicam—PTGS1—Metabolism—ALOX5—hematologic cancer	2.88e-05	0.000363	CbGpPWpGaD
Lornoxicam—PTGS2—Integrated Pancreatic Cancer Pathway—MAPK3—hematologic cancer	2.86e-05	0.000361	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism of lipids and lipoproteins—NCOR1—hematologic cancer	2.84e-05	0.000359	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism—ARNTL—hematologic cancer	2.84e-05	0.000358	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism—CDA—hematologic cancer	2.84e-05	0.000357	CbGpPWpGaD
Lornoxicam—PTGS2—Disease—NPM1—hematologic cancer	2.83e-05	0.000356	CbGpPWpGaD
Lornoxicam—PTGS1—Metabolism—NUP98—hematologic cancer	2.79e-05	0.000352	CbGpPWpGaD
Lornoxicam—PTGS2—Integrated Pancreatic Cancer Pathway—MYC—hematologic cancer	2.78e-05	0.000351	CbGpPWpGaD
Lornoxicam—PTGS2—Integrated Pancreatic Cancer Pathway—TGFB1—hematologic cancer	2.78e-05	0.00035	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism—CA9—hematologic cancer	2.76e-05	0.000348	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism—ACP5—hematologic cancer	2.76e-05	0.000348	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism—PC—hematologic cancer	2.73e-05	0.000344	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism—NCOR2—hematologic cancer	2.72e-05	0.000343	CbGpPWpGaD
Lornoxicam—PTGS1—Metabolism—ADCY7—hematologic cancer	2.71e-05	0.000341	CbGpPWpGaD
Lornoxicam—PTGS1—Metabolism—NCOA3—hematologic cancer	2.71e-05	0.000341	CbGpPWpGaD
Lornoxicam—PTGS2—Disease—FGF19—hematologic cancer	2.71e-05	0.000341	CbGpPWpGaD
Lornoxicam—PTGS1—Metabolism—NUP214—hematologic cancer	2.69e-05	0.000339	CbGpPWpGaD
Lornoxicam—PTGS2—Disease—RPS14—hematologic cancer	2.69e-05	0.000339	CbGpPWpGaD
Lornoxicam—PTGS2—Disease—DKK1—hematologic cancer	2.66e-05	0.000336	CbGpPWpGaD
Lornoxicam—PTGS1—Metabolism of lipids and lipoproteins—PIK3CG—hematologic cancer	2.66e-05	0.000335	CbGpPWpGaD
Lornoxicam—PTGS2—Disease—NUP98—hematologic cancer	2.64e-05	0.000333	CbGpPWpGaD
Lornoxicam—PTGS2—Disease—STAT5B—hematologic cancer	2.64e-05	0.000333	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism—GBA—hematologic cancer	2.64e-05	0.000332	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism—SLC35B2—hematologic cancer	2.64e-05	0.000332	CbGpPWpGaD
Lornoxicam—PTGS1—Metabolism—ABCG2—hematologic cancer	2.63e-05	0.000332	CbGpPWpGaD
Lornoxicam—PTGS1—Metabolism—MTR—hematologic cancer	2.63e-05	0.000332	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism—IDH1—hematologic cancer	2.59e-05	0.000327	CbGpPWpGaD
Lornoxicam—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—hematologic cancer	2.59e-05	0.000327	CbGpPWpGaD
Lornoxicam—PTGS2—Disease—CST3—hematologic cancer	2.59e-05	0.000326	CbGpPWpGaD
Lornoxicam—PTGS1—Metabolism—ENO2—hematologic cancer	2.58e-05	0.000326	CbGpPWpGaD
Lornoxicam—PTGS2—Integrated Pancreatic Cancer Pathway—KRAS—hematologic cancer	2.57e-05	0.000324	CbGpPWpGaD
Lornoxicam—PTGS2—Disease—ADCY7—hematologic cancer	2.57e-05	0.000324	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism—ABCC3—hematologic cancer	2.56e-05	0.000323	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism—TXN—hematologic cancer	2.56e-05	0.000323	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism—GSTO1—hematologic cancer	2.56e-05	0.000323	CbGpPWpGaD
Lornoxicam—PTGS2—Disease—NUP214—hematologic cancer	2.55e-05	0.000321	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism—SPHK1—hematologic cancer	2.51e-05	0.000316	CbGpPWpGaD
Lornoxicam—PTGS1—Metabolism—GSTT1—hematologic cancer	2.51e-05	0.000316	CbGpPWpGaD
Lornoxicam—PTGS2—Disease—MTR—hematologic cancer	2.5e-05	0.000315	CbGpPWpGaD
Lornoxicam—PTGS2—Disease—XIAP—hematologic cancer	2.5e-05	0.000315	CbGpPWpGaD
Lornoxicam—PTGS1—Metabolism of lipids and lipoproteins—CREBBP—hematologic cancer	2.47e-05	0.000311	CbGpPWpGaD
Lornoxicam—PTGS1—Metabolism—SDC1—hematologic cancer	2.45e-05	0.000309	CbGpPWpGaD
Lornoxicam—PTGS2—Disease—ENO2—hematologic cancer	2.45e-05	0.000309	CbGpPWpGaD
Lornoxicam—PTGS2—Disease—SMARCA4—hematologic cancer	2.43e-05	0.000307	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism—UGT1A1—hematologic cancer	2.41e-05	0.000304	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism—MTAP—hematologic cancer	2.41e-05	0.000304	CbGpPWpGaD
Lornoxicam—PTGS2—Integrated Pancreatic Cancer Pathway—PIK3CA—hematologic cancer	2.36e-05	0.000298	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism—SLC22A1—hematologic cancer	2.35e-05	0.000296	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism—CRABP1—hematologic cancer	2.35e-05	0.000296	CbGpPWpGaD
Lornoxicam—PTGS1—Metabolism of lipids and lipoproteins—PIK3CD—hematologic cancer	2.34e-05	0.000295	CbGpPWpGaD
Lornoxicam—PTGS2—Disease—SDC1—hematologic cancer	2.32e-05	0.000293	CbGpPWpGaD
Lornoxicam—PTGS1—Metabolism of lipids and lipoproteins—ALB—hematologic cancer	2.31e-05	0.000291	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism—ALOX5—hematologic cancer	2.29e-05	0.000288	CbGpPWpGaD
Lornoxicam—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—hematologic cancer	2.29e-05	0.000288	CbGpPWpGaD
Lornoxicam—PTGS2—Disease—LCK—hematologic cancer	2.25e-05	0.000283	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism—NUP98—hematologic cancer	2.21e-05	0.000279	CbGpPWpGaD
Lornoxicam—PTGS1—Metabolism of lipids and lipoproteins—PIK3R1—hematologic cancer	2.21e-05	0.000278	CbGpPWpGaD
Lornoxicam—PTGS2—Disease—H3F3A—hematologic cancer	2.2e-05	0.000278	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism—ADCY7—hematologic cancer	2.15e-05	0.000271	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism—NCOA3—hematologic cancer	2.15e-05	0.000271	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism—FHL2—hematologic cancer	2.15e-05	0.000271	CbGpPWpGaD
Lornoxicam—PTGS2—Disease—PRKCZ—hematologic cancer	2.14e-05	0.00027	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism—NUP214—hematologic cancer	2.13e-05	0.000269	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism of lipids and lipoproteins—PIK3CG—hematologic cancer	2.11e-05	0.000266	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism—AGRN—hematologic cancer	2.11e-05	0.000266	CbGpPWpGaD
Lornoxicam—PTGS2—Disease—CALR—hematologic cancer	2.1e-05	0.000265	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism—ABCG2—hematologic cancer	2.09e-05	0.000264	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism—MTR—hematologic cancer	2.09e-05	0.000264	CbGpPWpGaD
Lornoxicam—PTGS1—Metabolism—CD44—hematologic cancer	2.08e-05	0.000262	CbGpPWpGaD
Lornoxicam—PTGS1—Metabolism—NQO1—hematologic cancer	2.08e-05	0.000262	CbGpPWpGaD
Lornoxicam—PTGS2—Disease—PARP1—hematologic cancer	2.07e-05	0.000261	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism—ENO2—hematologic cancer	2.05e-05	0.000258	CbGpPWpGaD
Lornoxicam—PTGS1—Metabolism of lipids and lipoproteins—PIK3CB—hematologic cancer	2.04e-05	0.000257	CbGpPWpGaD
Lornoxicam—PTGS2—Disease—FBXW7—hematologic cancer	2.04e-05	0.000257	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism—HMMR—hematologic cancer	2e-05	0.000252	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism—IDH2—hematologic cancer	2e-05	0.000252	CbGpPWpGaD
Lornoxicam—PTGS2—Disease—HDAC2—hematologic cancer	2e-05	0.000252	CbGpPWpGaD
Lornoxicam—PTGS2—Disease—CXCR4—hematologic cancer	2e-05	0.000252	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism—GSTT1—hematologic cancer	1.99e-05	0.000251	CbGpPWpGaD
Lornoxicam—PTGS2—Disease—CD44—hematologic cancer	1.97e-05	0.000249	CbGpPWpGaD
Lornoxicam—PTGS1—Metabolism—CYCS—hematologic cancer	1.97e-05	0.000248	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism of lipids and lipoproteins—CREBBP—hematologic cancer	1.96e-05	0.000247	CbGpPWpGaD
Lornoxicam—PTGS1—Metabolism—HSP90AA1—hematologic cancer	1.96e-05	0.000247	CbGpPWpGaD
Lornoxicam—PTGS2—Disease—CBL—hematologic cancer	1.95e-05	0.000245	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism—SDC1—hematologic cancer	1.94e-05	0.000245	CbGpPWpGaD
Lornoxicam—PTGS2—Integrated Pancreatic Cancer Pathway—AKT1—hematologic cancer	1.93e-05	0.000243	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism of lipids and lipoproteins—NCOR1—hematologic cancer	1.88e-05	0.000237	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism—ARNTL—hematologic cancer	1.88e-05	0.000237	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism of lipids and lipoproteins—PIK3CD—hematologic cancer	1.86e-05	0.000234	CbGpPWpGaD
Lornoxicam—PTGS2—Disease—HSP90AA1—hematologic cancer	1.86e-05	0.000234	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism of lipids and lipoproteins—ALB—hematologic cancer	1.83e-05	0.000231	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism—ACP5—hematologic cancer	1.83e-05	0.00023	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism—CA9—hematologic cancer	1.83e-05	0.00023	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism—NCOR2—hematologic cancer	1.8e-05	0.000227	CbGpPWpGaD
Lornoxicam—PTGS2—Disease—STAT1—hematologic cancer	1.79e-05	0.000226	CbGpPWpGaD
Lornoxicam—PTGS1—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	1.76e-05	0.000222	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism of lipids and lipoproteins—PIK3R1—hematologic cancer	1.75e-05	0.000221	CbGpPWpGaD
Lornoxicam—PTGS1—Metabolism—GSTP1—hematologic cancer	1.74e-05	0.000219	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism—IDH1—hematologic cancer	1.72e-05	0.000217	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism—TXN—hematologic cancer	1.7e-05	0.000214	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism—ABCC3—hematologic cancer	1.7e-05	0.000214	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism—GSTO1—hematologic cancer	1.7e-05	0.000214	CbGpPWpGaD
Lornoxicam—PTGS1—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	1.68e-05	0.000212	CbGpPWpGaD
Lornoxicam—PTGS2—Disease—GRB2—hematologic cancer	1.67e-05	0.000211	CbGpPWpGaD
Lornoxicam—PTGS2—Disease—PDGFA—hematologic cancer	1.67e-05	0.00021	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism—SPHK1—hematologic cancer	1.66e-05	0.00021	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism—NQO1—hematologic cancer	1.65e-05	0.000208	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism—CD44—hematologic cancer	1.65e-05	0.000208	CbGpPWpGaD
Lornoxicam—PTGS2—Disease—KITLG—hematologic cancer	1.65e-05	0.000207	CbGpPWpGaD
Lornoxicam—PTGS1—Metabolism—ABCB1—hematologic cancer	1.64e-05	0.000207	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism of lipids and lipoproteins—PIK3CB—hematologic cancer	1.62e-05	0.000204	CbGpPWpGaD
Lornoxicam—PTGS2—Disease—STAT5A—hematologic cancer	1.61e-05	0.000203	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism—UGT1A1—hematologic cancer	1.6e-05	0.000201	CbGpPWpGaD
Lornoxicam—PTGS1—Metabolism—GSTM1—hematologic cancer	1.6e-05	0.000201	CbGpPWpGaD
Lornoxicam—PTGS1—Metabolism—NCOR1—hematologic cancer	1.6e-05	0.000201	CbGpPWpGaD
Lornoxicam—PTGS2—Disease—CDKN2B—hematologic cancer	1.59e-05	0.000201	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism—CYCS—hematologic cancer	1.56e-05	0.000197	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism—HSP90AA1—hematologic cancer	1.55e-05	0.000196	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism—SLC22A1—hematologic cancer	1.55e-05	0.000196	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism—CRABP1—hematologic cancer	1.55e-05	0.000196	CbGpPWpGaD
Lornoxicam—PTGS2—Disease—CD86—hematologic cancer	1.54e-05	0.000194	CbGpPWpGaD
Lornoxicam—PTGS2—Disease—HES1—hematologic cancer	1.52e-05	0.000192	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism—ALOX5—hematologic cancer	1.51e-05	0.000191	CbGpPWpGaD
Lornoxicam—PTGS2—Disease—NCOR1—hematologic cancer	1.51e-05	0.000191	CbGpPWpGaD
Lornoxicam—PTGS2—Disease—FGF1—hematologic cancer	1.5e-05	0.000189	CbGpPWpGaD
Lornoxicam—PTGS2—Disease—FOXO1—hematologic cancer	1.47e-05	0.000186	CbGpPWpGaD
Lornoxicam—PTGS2—Disease—PDGFRB—hematologic cancer	1.47e-05	0.000185	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism—NUP98—hematologic cancer	1.47e-05	0.000185	CbGpPWpGaD
Lornoxicam—PTGS2—Disease—PDGFRA—hematologic cancer	1.45e-05	0.000183	CbGpPWpGaD
Lornoxicam—PTGS2—Disease—PRKCG—hematologic cancer	1.44e-05	0.000182	CbGpPWpGaD
Lornoxicam—PTGS2—Disease—JAK1—hematologic cancer	1.44e-05	0.000182	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism—ADCY7—hematologic cancer	1.42e-05	0.000179	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism—NCOA3—hematologic cancer	1.42e-05	0.000179	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism—NUP214—hematologic cancer	1.41e-05	0.000178	CbGpPWpGaD
Lornoxicam—PTGS1—Metabolism—MTHFR—hematologic cancer	1.41e-05	0.000178	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—hematologic cancer	1.4e-05	0.000176	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	1.4e-05	0.000176	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism—ABCG2—hematologic cancer	1.38e-05	0.000175	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism—MTR—hematologic cancer	1.38e-05	0.000175	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism—GSTP1—hematologic cancer	1.38e-05	0.000174	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism—ENO2—hematologic cancer	1.36e-05	0.000171	CbGpPWpGaD
Lornoxicam—PTGS2—Disease—MTHFR—hematologic cancer	1.34e-05	0.000169	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	1.33e-05	0.000168	CbGpPWpGaD
Lornoxicam—PTGS2—Disease—TERT—hematologic cancer	1.33e-05	0.000168	CbGpPWpGaD
Lornoxicam—PTGS2—Disease—HLA-A—hematologic cancer	1.33e-05	0.000168	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism—GSTT1—hematologic cancer	1.32e-05	0.000166	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism—ABCB1—hematologic cancer	1.3e-05	0.000164	CbGpPWpGaD
Lornoxicam—PTGS2—Disease—PDGFB—hematologic cancer	1.3e-05	0.000164	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism of lipids and lipoproteins—CREBBP—hematologic cancer	1.3e-05	0.000163	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism—SDC1—hematologic cancer	1.29e-05	0.000162	CbGpPWpGaD
Lornoxicam—PTGS2—Disease—TSC2—hematologic cancer	1.27e-05	0.00016	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism—NCOR1—hematologic cancer	1.27e-05	0.00016	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism—GSTM1—hematologic cancer	1.27e-05	0.00016	CbGpPWpGaD
Lornoxicam—PTGS1—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	1.24e-05	0.000157	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—hematologic cancer	1.23e-05	0.000155	CbGpPWpGaD
Lornoxicam—PTGS2—Disease—FGFR3—hematologic cancer	1.22e-05	0.000154	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism of lipids and lipoproteins—ALB—hematologic cancer	1.21e-05	0.000153	CbGpPWpGaD
Lornoxicam—PTGS1—Metabolism—PIK3CG—hematologic cancer	1.18e-05	0.000149	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism of lipids and lipoproteins—PIK3R1—hematologic cancer	1.16e-05	0.000146	CbGpPWpGaD
Lornoxicam—PTGS2—Disease—BAD—hematologic cancer	1.16e-05	0.000146	CbGpPWpGaD
Lornoxicam—PTGS2—Disease—NOTCH1—hematologic cancer	1.15e-05	0.000145	CbGpPWpGaD
Lornoxicam—PTGS2—Disease—CD80—hematologic cancer	1.13e-05	0.000142	CbGpPWpGaD
Lornoxicam—PTGS2—Disease—KIT—hematologic cancer	1.12e-05	0.000142	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism—MTHFR—hematologic cancer	1.12e-05	0.000141	CbGpPWpGaD
Lornoxicam—PTGS2—Disease—PTPN11—hematologic cancer	1.1e-05	0.000139	CbGpPWpGaD
Lornoxicam—PTGS1—Metabolism—CREBBP—hematologic cancer	1.1e-05	0.000138	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism—NQO1—hematologic cancer	1.09e-05	0.000138	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism—CD44—hematologic cancer	1.09e-05	0.000138	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—hematologic cancer	1.07e-05	0.000135	CbGpPWpGaD
Lornoxicam—PTGS2—Disease—CREB1—hematologic cancer	1.07e-05	0.000135	CbGpPWpGaD
Lornoxicam—PTGS2—Disease—BRAF—hematologic cancer	1.06e-05	0.000133	CbGpPWpGaD
Lornoxicam—PTGS2—Disease—IL6R—hematologic cancer	1.04e-05	0.000131	CbGpPWpGaD
Lornoxicam—PTGS1—Metabolism—PIK3CD—hematologic cancer	1.04e-05	0.000131	CbGpPWpGaD
Lornoxicam—PTGS2—Disease—CREBBP—hematologic cancer	1.04e-05	0.000131	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism—CYCS—hematologic cancer	1.04e-05	0.000131	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism—HSP90AA1—hematologic cancer	1.03e-05	0.00013	CbGpPWpGaD
Lornoxicam—PTGS1—Metabolism—ALB—hematologic cancer	1.03e-05	0.00013	CbGpPWpGaD
Lornoxicam—PTGS2—Disease—MAP2K1—hematologic cancer	9.94e-06	0.000125	CbGpPWpGaD
Lornoxicam—PTGS2—Disease—PIK3CD—hematologic cancer	9.87e-06	0.000124	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	9.87e-06	0.000124	CbGpPWpGaD
Lornoxicam—PTGS1—Metabolism—PIK3R1—hematologic cancer	9.84e-06	0.000124	CbGpPWpGaD
Lornoxicam—PTGS2—Disease—FGF2—hematologic cancer	9.45e-06	0.000119	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism—PIK3CG—hematologic cancer	9.41e-06	0.000119	CbGpPWpGaD
Lornoxicam—PTGS2—Disease—PIK3R1—hematologic cancer	9.32e-06	0.000118	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	9.26e-06	0.000117	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism—GSTP1—hematologic cancer	9.13e-06	0.000115	CbGpPWpGaD
Lornoxicam—PTGS1—Metabolism—PIK3CB—hematologic cancer	9.08e-06	0.000114	CbGpPWpGaD
Lornoxicam—PTGS2—Disease—JAK2—hematologic cancer	9.06e-06	0.000114	CbGpPWpGaD
Lornoxicam—PTGS2—Disease—MDM2—hematologic cancer	8.85e-06	0.000112	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	8.83e-06	0.000111	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism—CREBBP—hematologic cancer	8.72e-06	0.00011	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism—ABCB1—hematologic cancer	8.64e-06	0.000109	CbGpPWpGaD
Lornoxicam—PTGS2—Disease—MTOR—hematologic cancer	8.61e-06	0.000108	CbGpPWpGaD
Lornoxicam—PTGS2—Disease—PIK3CB—hematologic cancer	8.61e-06	0.000108	CbGpPWpGaD
Lornoxicam—PTGS2—Disease—CD4—hematologic cancer	8.59e-06	0.000108	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism—GSTM1—hematologic cancer	8.39e-06	0.000106	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism—NCOR1—hematologic cancer	8.39e-06	0.000106	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism—PIK3CD—hematologic cancer	8.27e-06	0.000104	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism—ALB—hematologic cancer	8.16e-06	0.000103	CbGpPWpGaD
Lornoxicam—PTGS2—Disease—CDKN1B—hematologic cancer	8.08e-06	0.000102	CbGpPWpGaD
Lornoxicam—PTGS1—Metabolism—PTEN—hematologic cancer	7.85e-06	9.89e-05	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism—PIK3R1—hematologic cancer	7.81e-06	9.84e-05	CbGpPWpGaD
Lornoxicam—PTGS1—Metabolism—EP300—hematologic cancer	7.48e-06	9.43e-05	CbGpPWpGaD
Lornoxicam—PTGS2—Disease—CDKN1A—hematologic cancer	7.45e-06	9.4e-05	CbGpPWpGaD
Lornoxicam—PTGS2—Disease—PTEN—hematologic cancer	7.44e-06	9.37e-05	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism—MTHFR—hematologic cancer	7.41e-06	9.35e-05	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism—PIK3CB—hematologic cancer	7.21e-06	9.09e-05	CbGpPWpGaD
Lornoxicam—PTGS2—Disease—EP300—hematologic cancer	7.09e-06	8.94e-05	CbGpPWpGaD
Lornoxicam—PTGS2—Disease—SRC—hematologic cancer	6.9e-06	8.69e-05	CbGpPWpGaD
Lornoxicam—PTGS2—Disease—STAT3—hematologic cancer	6.65e-06	8.38e-05	CbGpPWpGaD
Lornoxicam—PTGS2—Disease—NRAS—hematologic cancer	6.63e-06	8.36e-05	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	6.53e-06	8.24e-05	CbGpPWpGaD
Lornoxicam—PTGS2—Disease—MAPK3—hematologic cancer	6.35e-06	8.01e-05	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism—PIK3CG—hematologic cancer	6.23e-06	7.85e-05	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism—PTEN—hematologic cancer	6.23e-06	7.85e-05	CbGpPWpGaD
Lornoxicam—PTGS2—Disease—MYC—hematologic cancer	6.18e-06	7.79e-05	CbGpPWpGaD
Lornoxicam—PTGS2—Disease—TGFB1—hematologic cancer	6.17e-06	7.77e-05	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism—EP300—hematologic cancer	5.94e-06	7.49e-05	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism—CREBBP—hematologic cancer	5.78e-06	7.28e-05	CbGpPWpGaD
Lornoxicam—PTGS2—Disease—KRAS—hematologic cancer	5.71e-06	7.2e-05	CbGpPWpGaD
Lornoxicam—PTGS1—Metabolism—PIK3CA—hematologic cancer	5.53e-06	6.98e-05	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism—PIK3CD—hematologic cancer	5.48e-06	6.9e-05	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism—ALB—hematologic cancer	5.41e-06	6.81e-05	CbGpPWpGaD
Lornoxicam—PTGS2—Disease—PIK3CA—hematologic cancer	5.25e-06	6.61e-05	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism—PIK3R1—hematologic cancer	5.17e-06	6.52e-05	CbGpPWpGaD
Lornoxicam—PTGS2—Disease—HRAS—hematologic cancer	4.85e-06	6.12e-05	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism—PIK3CB—hematologic cancer	4.77e-06	6.02e-05	CbGpPWpGaD
Lornoxicam—PTGS2—Disease—IL6—hematologic cancer	4.65e-06	5.86e-05	CbGpPWpGaD
Lornoxicam—PTGS1—Metabolism—AKT1—hematologic cancer	4.52e-06	5.7e-05	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism—PIK3CA—hematologic cancer	4.39e-06	5.54e-05	CbGpPWpGaD
Lornoxicam—PTGS2—Disease—AKT1—hematologic cancer	4.29e-06	5.4e-05	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism—PTEN—hematologic cancer	4.12e-06	5.2e-05	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism—EP300—hematologic cancer	3.93e-06	4.96e-05	CbGpPWpGaD
Lornoxicam—PTGS2—Metabolism—AKT1—hematologic cancer	3.59e-06	4.52e-05	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism—PIK3CA—hematologic cancer	2.91e-06	3.67e-05	CbGpPWpGaD
Lornoxicam—CYP2C9—Metabolism—AKT1—hematologic cancer	2.38e-06	3e-05	CbGpPWpGaD
